BIIB129
BIIB129 is a brain-penetrant, covalent BTK inhibitor used for research into B-cell driven pathologies. It is employed in both in vitro and in vivo studies to investigate mechanisms of B-cell proliferation and related autoimmune or oncological diseases.
Product Specifications
CAS Number
2770960-52-4
Product Name Alternative
BIIB 129
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.56% (May vary between batches)
Solubility
DMSO:80 mg/mL (218.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (9.01 mM)
Smiles
O (C=1C=2N (C=C (N1) C3=CN (C) N=C3) N=CC2) [C@@]4 (C) C[C@@H] (N (C (C=C) =O) C) C4
Molecular Formula
C19H22N6O2
Molecular Weight
366.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
R0495-10E-ML405 100 µL
Raf, phosphorylated (Ser338, Tyr340) (Raf1, c-Raf) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
MBS958697-01 0.02 mg (E-Coli)
Recombinant Human Alpha-2A adrenergic receptor (ADRA2A), partial
Sign In for Pricing
View Details 
MBS958697-02 0.1 mg (E-Coli)
Recombinant Human Alpha-2A adrenergic receptor (ADRA2A), partial
Sign In for Pricing
View Details MBS958697-03 0.02 mg (Yeast)
Recombinant Human Alpha-2A adrenergic receptor (ADRA2A), partial
Sign In for Pricing
View Details MBS958697-04 0.1 mg (Yeast)
Recombinant Human Alpha-2A adrenergic receptor (ADRA2A), partial
Sign In for Pricing
View Details 
MBS958697-05 0.02 mg (Baculovirus)
Recombinant Human Alpha-2A adrenergic receptor (ADRA2A), partial
Sign In for Pricing
View Details